Castellan Group: NEE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Castellan Group on NEE, newest first. How the timeline and the estimate are built.
Castellan Group held 52,238 NEE shares at 2026-06-30 per its 13F-HR filed 2026-07-23.
the latest 13F is the newest step
- period ended2026-06-3013F 52,238 sharesChange vs previous 13F -1,857 shares
0.5% of the 13F portfolio, value $4,584,929.
13F-HR 0001832521-26-000003 filed by Castellan Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 54,095 sharesChange vs previous 13F +2,171 shares
0.7% of the 13F portfolio, value $5,024,344.
13F-HR 0001832521-26-000002 filed by Castellan Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 51,924 sharesChange vs previous 13F +3,738 shares
0.53% of the 13F portfolio, value $4,168,459.
13F-HR 0001832521-26-000001 filed by Castellan Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 48,186 sharesChange vs previous 13F +1,380 shares
0.53% of the 13F portfolio, value $3,637,561.
13F-HR 0001832521-25-000008 filed by Castellan Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F/A 46,806 sharesChange vs previous 13F +3,210 shares
0.6% of the 13F portfolio, value $3,249,273.
13F-HR/A 0001832521-25-000006 filed by Castellan Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 43,596 sharesChange vs previous 13F not available
0.86% of the 13F portfolio, value $3,090,520.
13F-HR 0001832521-25-000004 filed by Castellan Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).